Searchable abstracts of presentations at key conferences in endocrinology

ea0065p351 | Reproductive Endocrinology and Biology | SFEBES2019

Igf2 regulates placental endocrine capacity in the mouse placenta

Aykroyd Bethany , Tunster Simon , Sferruzzi-Perri Amanda

Introduction: Abnormal fetal growth can cause perinatal morbidity and mortality. The placenta regulates materno-fetal nutrient transfer and secretes hormones with maternal physiological effects. In mice, global loss of insulin-like growth factor 2 (Igf2), a paternally-expressed imprinted gene, causes fetoplacental growth restriction in association with changes in placental transport and endocrine zone (Jz) formation. However, the role of Igf2 in regulating pl...

ea0031p289 | Pituitary | SFEBES2013

Maternal corticosterone regulates amino acid allocation to fetal growth in mice

Vaughan Owen , Sferruzzi-Perri Amanda , Fowden Abigail

Synthetic glucocorticoid administration during pregnancy reduces birth weight and increases disease risk in the offspring. This study investigated whether increasing maternal natural corticosterone levels, by endogenous stress or exogenous administration, alters fetal amino acid supply in the mouse.C57BL6/J dams (n=82) were exposed to daily restraint and subcutaneous saline injection (stress) or given corticosterone (cort, 82±11 &#...

ea0011p829 | Thyroid | ECE2006

Safety of pharmacological treatment of thyroid diseases during pregnancy

Gianetti E , Tonacchera M , Russo L , Perri A , Vitti P , Pinchera A

Pregnant women may require treatment of hypo- or hyperthyroidism, L-thyroxine (LT4), propylthiouralcil (PTU) and methimazole (MMI) being the most frequently used drugs. Aim of this study was to verify the consequences on both the mother and the fetus of pharmacological treatment during pregnancy. We retrospectively evaluated 292 pregnancies: 63 patients under MMI treatment, 8 of whom (7 Graves’ (GD) and 1 toxic nodular goiter) still hyperthyroid in spite of treatment (H-M...

ea0011p830 | Thyroid | ECE2006

Increase of L-thyroxine requirement during pregnancy

Russo L , Tonacchera M , Gianetti E , Perri A , Vitti P , Pinchera A

In pregnant women with thyroid diseases an increased amount of LT4 may be required for the correction of hypothyroidism or treatment of nodular goiter. Aim of this study was to assess the amount of the variations of LT4 requirement in pregnant women with thyroid diseases. To address this issue, we retrospectively evaluated a cohort of 107 women treated with LT4 divided in two groups: 42 euthyroid (E) (affected by nodular goiter (NG) treated with LT4 suppressive therapy) and 65...

ea0065p355 | Reproductive Endocrinology and Biology | SFEBES2019

Identifying placental hormones regulating maternal physiology during pregnancy – potential diagnostic and treatment markers for pregnancy complications

Napso Tina , Zhao Xiaohui , Lopez-Tello Jorge , Hamilton Russell S. , Sferruzzi-Perri Amanda N

Pregnancy is characterised by profound changes in maternal physiology. For instance, there are changes in the metabolic, cardiovascular, immune and renal systems of the mother which enable her to support fetal nutrient supply and growth. These changes are signalled in part by the production of protein hormones by the placenta (Napso et al., 2018). Failures in maternal adaptation and placental function lead to pregnancy complications such as abnormal birth weight and g...

ea0099p561 | Reproductive and Developmental Endocrinology | ECE2024

In vitro analysis of FSHR internalization and signalling mediated by two different FSH preparations

Baschieri Lara , Lazzaretti Clara , Mascolo Elisa , Perri Carmela , Sperduti Samantha , Fusco Claudia , Simoni Manuela , Casarini Livio

Follicle stimulating hormone (FSH) is produced by the anterior pituitary gland and is a key hormone in the reproductive system. FSH is a heterodimeric glycoprotein composed with two extensively glycosylated protein subunits (α and β) N-glycosylated in two positions (Asn52 and Asn78in the FSHα subunit and Asn7 and Asn24 in the FSHβ subunit). Due to different glycosylation pattern, several FSH isoforms may different...

ea0090p468 | Reproductive and Developmental Endocrinology | ECE2023

In vitro evaluation of the impact of two differently glycosylated recombinant FSH on signal transduction

Mascolo Elisa , Baschieri Lara , Roy Neena , Lazzaretti Clara , Paradiso Elia , Perri Carmela , Sperduti Samantha , Simoni Manuela , Casarini Livio

Follicle stimulating hormone (FSH) is produced by the anterior pituitary gland and it is a key hormone in the reproductive system. FSH is a heterodimeric glycoprotein composed with two extensively glycosylated protein sobunits (α and β) N-glycosylated in two positions (Asn52 and Asn78 in the FSHα subunit and Asn7 and Asn24 in the FSHβ subunit) giving rise to numerous isoforms of FSH. Glycosylation has been shown t...

ea0070aep782 | Reproductive and Developmental Endocrinology | ECE2020

New data in turner syndrome: Results from a long-term prospective observational study from diagnosis to adulthood

Corzani Francesca , Cecchetti Carolina , Oriolo Claudia , Altieri Paola , Perri Annamaria , Scarano Emanuela , Mazzanti Laura , Pagotto Uberto , Gambineri Alessandra

Turner syndrome (TS), one of the most frequent chromosomal aberrations in females, is characterized not only by structural abnormalities (somatic and congenital) but also by acquired comorbidities, such as metabolic disorders, cardiovascular alterations, autoimmune diseases, osteoporosis, and malignancies. The prevalence of structural abnormalities that usually complicate TS at diagnosis is well known. However, the prevalence of acquired complications, that may appear at any a...

ea0011p823 | Thyroid | ECE2006

Etiology of congenital hypothyroidism in children with a normal located thyroid gland

Di Cosmo C , Tonacchera M , De Marco G , Agretti P , Banco ME , Perri A , Ramos H , Ceccarelli C , Vitti P , Pinchera A

Congenital hypothyroidism (CH) with a normal located thyroid gland may be transient or permanent and environmental, iatrogenic, immunologic or genetic factors can be involved. PAX-8, TSH receptor and THOX2 gene mutations have been identified in cases of CH with a gland of normal size.In this study we performed genetic analysis of PAX8, TSH receptor and THOX2 genes in 14 children with CH and a normal sized eutopic gland. Genomic DNA was extracted from lym...

ea0099p385 | Thyroid | ECE2024

hCG-TSHR cross-interaction: a rationale for in hyperemesis gravidarum?

Perri Carmela , Lazzaretti Clara , Baschieri Lara , Marchetti Lorenzo , Sperduti Samantha , Fusco Claudia , Simoni Manuela , Brigante Giulia , Casarini Livio

About 50% of women have nausea and vomiting during pregnancy. In about 35% of women who have these symptoms, nausea and vomiting are clinically significant, worsening their living conditions and consisting in a case of gender gap. The severe form, hyperemesis gravidarum, ranges from 0.3 to 1.0% of cases and is characterized by persistent vomiting, gestational thyrotoxicosis, weight loss of more than 5%, ketonuria, hypokalemia and dehydration, although the pathophysiological me...